Component
Cardiovascular risk markers in adults with diabetes
Species, preparation, dose and limitations are retained on linked claims.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
In 68 adults with diabetes, 1050 mg/day bromelain for 12 weeks did not significantly improve fibrinogen, lipids, blood pressure, glucose, C-reactive protein, or anthropometric measures versus placebo.
Experimental context and source evidence
- dose
- Bromelain 1050 mg/day
- duration
- 12 weeks
- evidence_access
- Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
- evidence_scope
- literature_reviewed; model-specific source-derived curation
- experimental_model
- Sixty-eight Chinese adults with diabetes and at least one cardiovascular risk factor
- limitations
- Baseline fibrinogen differed despite randomization; the result is a clinical null for the tested dose and population, not proof of no effect in every setting.
- nutrient_topic
- Bromelain chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings. · Bromelain
- organism
- Sixty-eight Chinese adults with diabetes and at least one cardiovascular risk factor
- plain_language
- In 68 adults with diabetes, 1050 mg/day bromelain for 12 weeks did not significantly improve fibrinogen, lipids, blood pressure, glucose, C-reactive protein, or anthropometric measures versus placebo.
- primary_references
- Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial. (2016). https://pubmed.ncbi.nlm.nih.gov/27412590/ DOI: 10.1007/s11655-016-2521-2
- route
- Oral
- tissue
- Randomized double-blind placebo-controlled trial
Bromelain: mechanism of action and interactions (2026-09-20) · lines 132–141
Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text. · supports · Sixty-eight Chinese adults with diabetes and at least one cardiovascular risk factor · source_derived_draft · unverified_draft
## bromelain-diabetes-rct-null In 68 adults with diabetes, 1050 mg/day bromelain for 12 weeks did not significantly improve fibrinogen, lipids, blood pressure, glucose, C-reactive protein, or anthropometric measures versus placebo. Model/species: Sixty-eight Chinese adults with diabetes and at least one cardiovascular risk factor Tissue/system: Randomized double-blind placebo-controlled trial Exposure: Bromelain 1050 mg/day Route: Oral Duration: 12 weeks Limits: Baseline fibrinogen differed despite randomization; the result is a clinical null for the tested dose and population, not proof of no effect in every setting. Primary reference: Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial. (2016). https://pubmed.ncbi.nlm.nih.gov/27412590/ DOI: 10.1007/s11655-016-2521-2 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.